REGENXBIO
RGNX
#7519
Rank
HK$3.71 B
Marketcap
HK$56.12
Share price
-0.28%
Change (1 day)
-38.88%
Change (1 year)

EPS for REGENXBIO (RGNX)

EPS in 2026 (TTM): -HK$25.09

According to REGENXBIO's latest financial reports the company's current EPS (TTM) is -HK$25.16. In 2025 the company made an earnings per share (EPS) of -HK$29.47 an increase over its 2024 EPS that were of -HK$36.14.

EPS history for REGENXBIO from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$25.09-14.87%
2025-HK$29.47-18.44%
2024-HK$36.14
2022-HK$50.95-321.09%
2021HK$23.05-198.33%
2020-HK$23.4415.44%
2019-HK$20.30-181.19%
2018HK$25.01-229.15%
2017-HK$19.363.35%
2016-HK$18.735.42%
2015-HK$17.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58-57.94%๐Ÿ‡บ๐Ÿ‡ธ USA